Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral Progesterone for Prevention of Miscarriage in Threatened Abortion: a Randomized, Double-blinded, Placebo-controlled Trial

NCT04788108 is registered in ClinicalTrials.gov with Chulalongkorn University as lead sponsor.

NCT NCT04788108
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04788108 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion: a Randomized, Double-blinded, Placebo-controlled Trial
Lead sponsor
Chulalongkorn University
Phase
Phase 4
Overall status
Completed
Start date
August 1, 2021
Completion date
August 31, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

threatened abortion